InfuSystem Holdings (INFU) Non-Current Assets (2010 - 2026)
InfuSystem Holdings (INFU) posted Non-Current Assets of $62.0 million for Q1 2026, down 3.47% on a QoQ basis from $64.2 million in Q4 2025, and down 10.1% year-over-year from $69.0 million in Q1 2025.
InfuSystem Holdings (INFU) Non-Current Assets (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Non-Current Assets history runs 17 years deep, the most recent figure standing at $62.0 million for Q1 2026.
- Quarterly Non-Current Assets fell 10.1% year-over-year to $62.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $255.6 million (down 11.17% YoY) and the FY2025 annual result came in at $64.2 million, down 10.11% from the prior year.
- Non-Current Assets was $62.0 million for Q1 2026 at InfuSystem Holdings, down from $64.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $75.9 million in Q2 2022 and bottomed at $62.0 million in Q1 2026.
- A 5-year average of $71.2 million and a median of $72.4 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets increased 11.74% — and 2025, when it decreased 12.65%.
- InfuSystem Holdings' Non-Current Assets stood at $74.6 million in 2022, then slipped by 3.1% to $72.3 million in 2023, then decreased by 1.17% to $71.4 million in 2024, then declined by 10.11% to $64.2 million in 2025, then dropped by 3.47% to $62.0 million in 2026.
- Business Quant data shows INFU's Non-Current Assets at $62.0 million in Q1 2026, $64.2 million in Q4 2025, and $63.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 62.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 64.22 Mn |
| Sep 30, 2025 | 63.31 Mn |
| Jun 30, 2025 | 66.05 Mn |
| Mar 31, 2025 | 68.96 Mn |
| Dec 31, 2024 | 71.45 Mn |
| Sep 30, 2024 | 71.69 Mn |
| Jun 30, 2024 | 75.61 Mn |
| Mar 31, 2024 | 72.39 Mn |
| Dec 31, 2023 | 72.30 Mn |
| Sep 30, 2023 | 72.35 Mn |
| Jun 30, 2023 | 74.12 Mn |
| Mar 31, 2023 | 74.34 Mn |
| Dec 31, 2022 | 74.61 Mn |
| Sep 30, 2022 | 75.33 Mn |
| Jun 30, 2022 | 75.86 Mn |
| Mar 31, 2022 | 74.98 Mn |
| Dec 31, 2021 | 75.52 Mn |
| Sep 30, 2021 | 72.92 Mn |
| Jun 30, 2021 | 74.32 Mn |